Is Saudi Pharmaceutical stock a buy?

Yes, Saudi Pharmaceutical pays dividends. Last time was Monday 27th of June 2022 where the investors holding the stock on Thursday 9th of June 2022 were paid SAR0.6 per share. Over the last 13 times between 2011 and 2022, Saudi Pharmaceutical has paid SAR15.1298 with an average of SAR1.16 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Saudi Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SAR25.85, you would have made a profit of SAR6.65 per share or 25.73%

Yes, the average daily trading liquidity for Saudi Pharmaceutical is SAR1.20 million. You should therefore be able to get in and out of your positions relatively fast.

Saudi Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.13, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Saudi Pharmaceutical to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.